BioXcel Therapeutics Inc BTAI:NASDAQ

Last Price$14.60Cboe Real-Time Last Sale as of 9:35AM ET 8/17/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.27(1.82%)
Bid (Size)$14.65 (100)
Ask (Size)$14.96 (400)
Day Low / High$14.60 - 14.70

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

9:13AM ET 12/01/2021 MT Newswires
Health care stocks were edging higher premarket Wednesday as the iShares NASDAQ Biotechnology Index (IBB) was up 0.50% and the Health Care SPDR (XLV) was recently climbing by 0.51%.

BeyondSpring (BYSI) was retreating by more than 51% after saying the US Food and Drug Administration rejected its new drug application seeking approval of plinabulin in combination with granulocyte to prevent chemotherapy-induced neutropenia.

BioXcel Therapeutics (BTAI) was down more than 17% after saying the FDA has extended the Prescription Drug User Fee Act date for its review of the new-drug application of BXCL501 to treat agitation associated with schizophrenia and bipolar disorder to April 5 from Jan. 5.

Bright Health Group's (BHG) NeueHealth unit said it plans to open at least 25 clinics in Florida, Texas, and North Carolina, taking its total to more than 70 owned clinics by early 2022. Bright Health Group was climbing past 2% in recent trading.